论文部分内容阅读
方法:研究对象为20例室性心律失常患者。随机口服Ⅰ类抗心律失常新药西本唑啉(Cibenzoline)130 mg,每日2次或奎尼丁300mg,每6小时1次;4天后室性早搏次数减少≥75%,则继续该剂量治疗1周。否则剂量改为西本唑啉160mg每日2次或奎尼丁400mg每6小时1次,如第11日的早搏次数减少≥75%,再维持该剂量1周;否则停药。两药交换。8例长程西本唑啉治疗。结果:患者治疗前室性早搏次数平均每
Methods: The subjects were 20 patients with ventricular arrhythmia. Randomized to oral administration of class I antiarrhythmic drugs Cibenzoline 130 mg twice daily or quinidine 300 mg every 6 hours 4 days after the reduction in the number of premature ventricular contractions ≥ 75%, then the dose of treatment 1 week. Otherwise, the dose should be changed to western medicine xanthoxamine 160mg twice daily or quinidine 400mg once every 6 hours, such as reducing the number of premature beats on the 11th day ≥75%, and then maintaining the dose for one week; otherwise stopping. Two drugs exchange. 8 cases of long-term treatment with western medicine. Results: The average number of premature ventricular contractions in patients per treatment